ELLI, ELENA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.368
EU - Europa 1.161
AS - Asia 464
SA - Sud America 46
AF - Africa 3
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.046
Nazione #
US - Stati Uniti d'America 1.351
IT - Italia 357
DE - Germania 212
RU - Federazione Russa 208
SG - Singapore 196
IE - Irlanda 128
CN - Cina 109
SE - Svezia 103
HK - Hong Kong 72
BR - Brasile 38
GB - Regno Unito 32
UA - Ucraina 27
FR - Francia 25
ID - Indonesia 24
CA - Canada 15
FI - Finlandia 15
NL - Olanda 15
IN - India 14
ES - Italia 10
TR - Turchia 10
CZ - Repubblica Ceca 9
VN - Vietnam 8
JP - Giappone 7
AR - Argentina 6
AT - Austria 5
IR - Iran 4
RO - Romania 4
AU - Australia 3
NO - Norvegia 3
AM - Armenia 2
BG - Bulgaria 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PH - Filippine 2
PK - Pakistan 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BE - Belgio 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PA - Panama 1
PT - Portogallo 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.046
Città #
Ann Arbor 301
Frankfurt am Main 141
Singapore 131
Dublin 126
Chandler 122
Milan 103
Woodbridge 90
Fairfield 89
Houston 72
Hong Kong 70
Ashburn 65
Wilmington 55
New York 54
Santa Clara 41
Shanghai 40
Seattle 32
Princeton 30
Cambridge 26
Dearborn 25
Jacksonville 25
Jakarta 23
Altamura 22
Los Angeles 22
Romola 18
Lawrence 15
Munich 15
Council Bluffs 14
Rome 13
Moscow 12
Genoa 9
Turin 9
Dong Ket 8
Guangzhou 8
Helsinki 8
London 8
Nuremberg 8
Carate Brianza 7
Olomouc 7
Andover 6
Beijing 6
Cinisello Balsamo 6
Como 6
Fremont 6
Monza 6
Ottawa 6
Pune 6
Chicago 5
Falls Church 5
Meda 5
Nanjing 5
St Petersburg 5
Assago 4
Boardman 4
Bologna 4
Changsha 4
Lachine 4
Nanchang 4
Redmond 4
San Diego 4
Tianjin 4
Tokyo 4
Turda 4
Bari 3
Ceret 3
Cesena 3
Desio 3
Düsseldorf 3
Florence 3
Göttingen 3
Jinan 3
Lappeenranta 3
Lauterbourg 3
Lleida 3
Portsmouth 3
São Paulo 3
Taiyuan 3
Toronto 3
Vienna 3
Agrate Brianza 2
Amman 2
Athens 2
Bishkek 2
Brno 2
Buenos Aires 2
Cesano Maderno 2
Chengdu 2
Colombo 2
Corbetta 2
Coventry 2
Dallas 2
Delhi 2
Dresden 2
Esslingen am Neckar 2
Fidenza 2
Glendale 2
Hebei 2
Islamabad 2
Konya 2
L'Hospitalet de Llobregat 2
Lissone 2
Totale 2.073
Nome #
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 228
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 221
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 216
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 209
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 206
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT 196
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 190
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection 176
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 172
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 146
Idiopathic erythrocytosis: a germline disease? 132
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 127
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study 127
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 109
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study 102
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 97
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review 95
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 91
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 85
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 80
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 78
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 25
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 21
Totale 3.129
Categoria #
all - tutte 12.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 12 12 3
2020/2021410 27 19 67 52 31 40 26 34 30 23 40 21
2021/2022217 17 12 18 21 16 19 1 11 16 19 27 40
2022/2023527 45 148 65 50 25 78 11 27 38 5 10 25
2023/2024569 16 25 24 35 58 132 96 22 50 28 25 58
2024/2025995 60 99 79 78 109 65 71 50 148 236 0 0
Totale 3.129